Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of RLYB116 in Healthy Participants

Clinical trial NCT06797375 · COMPLETED

Trial details

NCT number: NCT06797375
Sponsor: Rallybio
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Hematologic Diseases Autoimmune Diseases

Start date: 2025-04-14
Primary completion: 2026-02-09
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.